John Alexander

Nov 11, 2023 | jacc.org | Björn Redfors |Gregg W. Stone |John Alexander |Eric Bates

AbstractBackgroundIn the ISCHEMIA trial, the risk of ischemic events was similar in patients with stable coronary artery disease treated with an invasive (INV) strategy of angiography and percutaneous (PCI) or surgical (CABG) coronary revascularization and a conservative (CON) strategy of initial medical therapy. ObjectiveTo analyze separately the outcomes of INV patients treated with PCI or CABG.